Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma. - Wikidata - awgldk - TriplyDB

Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma.

Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma.

http://www.wikidata.org/entity/Q37355439

about

Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas.Convection-enhanced delivery of etoposide is effective against murine proneural glioblastoma.Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients Canadian recommendations for the treatment of glioblastoma multiforme.The role of radiotherapy and chemotherapy in the treatment of primary adult high grade gliomas: assessment of patients for these treatment approaches and the common immediate side effects.Management and treatment recommendations for World Health Organization Grade III and IV gliomas.Constitutive Notch2 signaling in neural stem cells promotes tumorigenic features and astroglial lineage entry

P2860

Q33973844-668BF9D8-349E-4A35-9462-FF0F4C70F4E1 Q34062017-AA82C8FF-BB6D-4602-9F64-147A4FBD7CC8 Q35018538-189A0E04-2515-4A0F-AB7A-B0E25257E635 Q35855352-3B8B6A72-1CF1-49C7-AC8D-369D595057DF Q36487745-1D8B17D1-8D31-49A8-B269-08A7F2415D09 Q41706326-AF9681D2-6C91-407C-B71F-7B398545A853 Q42222863-7F17F4EC-A142-45CE-975B-A4ED77E65B92

P2860

Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma.

http://www.wikidata.org/entity/Q37355439

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Phase II trial of carboplatin ...... h recurrent high-grade glioma.

@en

Phase II trial of carboplatin ...... h recurrent high-grade glioma.

@nl

type

label

Phase II trial of carboplatin ...... h recurrent high-grade glioma.

@en

Phase II trial of carboplatin ...... h recurrent high-grade glioma.

@nl

prefLabel

Phase II trial of carboplatin ...... h recurrent high-grade glioma.

@en

Phase II trial of carboplatin ...... h recurrent high-grade glioma.

@nl

P1433

Q37355439-3503234A-1B0B-4129-B388-881ECA7A3A70

P1476

Q37355439-69696762-0E88-49C0-8E64-B07C26758456

P2093

Q37355439-19528643-F235-4097-B777-FCAF655D36D7

Q37355439-480E0856-3F99-4F4E-B48C-5272BBC59ABC

Q37355439-5AD35EA9-A36B-4287-B46F-778F802E1D72

Q37355439-71DA9043-187B-4323-B398-6211F4EF59A4

Q37355439-7F314A4B-3B8E-499E-ABA4-26D1C8AFCEBB

Q37355439-8C026191-3B43-43F3-9F2C-BF97AD4B7AAB

Q37355439-92902C9A-738D-4747-97CF-72C7A412F088

Q37355439-97514302-A790-4277-A75C-07D531D6F8F1

Q37355439-B4B47763-60E1-4A5B-8769-72050BA91823

Q37355439-BC4529C5-3911-405A-8B8D-9F620137055D

P2860

Q37355439-06FEB280-A9EF-4EC3-9FFD-6DB83790B702

Q37355439-0D8EBFC6-3D1B-43BC-AE64-93CAF3129C95

Q37355439-0E529410-4D17-4272-B850-55F88EC992E3

Q37355439-146682F9-3996-4831-A7D0-4EDBBF370DAB

Q37355439-14980C42-C64C-4291-8BB0-9DE2F4B48334

Q37355439-1F24E658-5D75-4C04-9D66-68D345A913EA

Q37355439-2D28FD79-5C9D-4E11-9439-858BA71D5FF1

Q37355439-45EC341B-F0B9-470A-8A38-8D4393A112BD

Q37355439-48EC68DD-B7ED-499A-A842-63BDD45D5394

Q37355439-523E7E9B-795A-4BF8-9969-B6703F8122A1

P2888

Q37355439-DA6816B6-6FC0-41EE-9DFA-27F9A7E60D8E

P304

Q37355439-28B147AD-FBB8-4EDA-94A6-AAE99D4FD236

P31

Q37355439-5BA02FB4-6569-466F-A81E-6B9F5448A79E

P356

Q37355439-1299084E-233C-477F-8AD4-06B68CF000E4

P407

Q37355439-35FD1480-1E17-4BE4-99F8-0676E3D599BA

P433

Q37355439-D33610AA-30E0-412B-A632-E40E27FAD699

P478

Q37355439-F320203A-EE7E-4B12-B0FE-717F3D796773

P50

Q37355439-13818C7B-44D4-4A02-AE64-C6F4E83F5ADD

Q37355439-5234A639-C33D-4A15-A913-8080291F68D7

P577

Q37355439-B5DE1AD0-1762-4D32-8231-14C39BCB24FB

P5875

Q37355439-8BDB61F8-B35A-4B8E-B5F6-E5AD9687E8CF

P6179

Q37355439-E3175C3C-35C0-4392-8BE3-C47917672C13

P698

Q37355439-B0779461-0960-4FE0-8F9B-C5ABEDB6C8FB

P921

Q37355439-4C2E5D46-E743-4362-B3F3-432442F17558

P932

Q37355439-0BBF1536-B89E-430B-9B28-C86F288F53F8

P356

P1433

British Journal of Cancer

P1476

Phase II trial of carboplatin ...... h recurrent high-grade glioma.

@en

P2093

A Paioli

http://www.w3.org/2001/XMLSchema#string

E Franceschi

http://www.w3.org/2001/XMLSchema#string

E Magrini

http://www.w3.org/2001/XMLSchema#string

G Cavallo

http://www.w3.org/2001/XMLSchema#string

L Crinò

http://www.w3.org/2001/XMLSchema#string

L Scopece

http://www.w3.org/2001/XMLSchema#string

R Conforti

http://www.w3.org/2001/XMLSchema#string

R Degli Esposti

http://www.w3.org/2001/XMLSchema#string

S Bartolini

http://www.w3.org/2001/XMLSchema#string

S Rimondini

http://www.w3.org/2001/XMLSchema#string

P2860

Etoposide: four decades of development of a topoisomerase II inhibitor

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples.

Carboplatin and etoposide for recurrent malignant glioma following surgical and radiotherapy failure: A clinical study conducted at the Northern Israel Oncology Center.

Phase II study of carboplatin in children with progressive low-grade gliomas.

Pharmacokinetic study of cisplatin and infusional etoposide phosphate in advanced breast cancer with correlation of response to topoisomerase IIalpha expression.

Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study.

Intravenous carboplatin for recurrent malignant glioma: a phase II study.

Activity and toxicity of carboplatin and iproplatin in relapsed high-grade glioma.

A phase II study of intravenous carboplatin for the treatment of recurrent gliomas.

P2888

P304

1038-1044

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6602105

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

Emanuela Palmerini

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232763510

http://www.w3.org/2001/XMLSchema#string

P6179

1008198089

http://www.w3.org/2001/XMLSchema#string

P698

15305187

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

P932

2747702

http://www.w3.org/2001/XMLSchema#string